| Literature DB >> 26028537 |
Christl Gaubitz1, Taiana M Oliveira2, Manoel Prouteau1, Alexander Leitner3, Manikandan Karuppasamy4, Georgia Konstantinidou1, Delphine Rispal1, Sandra Eltschinger1, Graham C Robinson1, Stéphane Thore5, Ruedi Aebersold6, Christiane Schaffitzel7, Robbie Loewith8.
Abstract
Target of Rapamycin (TOR) plays central roles in the regulation of eukaryote growth as the hub of two essential multiprotein complexes: TORC1, which is rapamycin-sensitive, and the lesser characterized TORC2, which is not. TORC2 is a key regulator of lipid biosynthesis and Akt-mediated survival signaling. In spite of its importance, its structure and the molecular basis of its rapamycin insensitivity are unknown. Using crosslinking-mass spectrometry and electron microscopy, we determined the architecture of TORC2. TORC2 displays a rhomboid shape with pseudo-2-fold symmetry and a prominent central cavity. Our data indicate that the C-terminal part of Avo3, a subunit unique to TORC2, is close to the FKBP12-rapamycin-binding domain of Tor2. Removal of this sequence generated a FKBP12-rapamycin-sensitive TORC2 variant, which provides a powerful tool for deciphering TORC2 function in vivo. Using this variant, we demonstrate a role for TORC2 in G2/M cell-cycle progression.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26028537 DOI: 10.1016/j.molcel.2015.04.031
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970